# Effect of Enalapril and Losartan Association Therapy on Proteinuria and Inflammatory Biomarkers in Diabetic Nephropathy: a Clinical Trial on Type 2 Diabetes Mellitus

> **NCT00419835** · PHASE4 · COMPLETED · sponsor: **University of Sao Paulo** · enrollment: 80 (actual)

## Conditions studied

- Macroalbuminuric Diabetic Nephropathy

## Interventions

- **DRUG:** enalapril
- **DRUG:** losartan

## Key facts

- **NCT ID:** NCT00419835
- **Lead sponsor:** University of Sao Paulo
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-05
- **Primary completion:** 2007-09
- **Final completion:** 2007-09
- **Target enrollment:** 80 (ACTUAL)
- **Last updated:** 2011-08-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00419835

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00419835, "Effect of Enalapril and Losartan Association Therapy on Proteinuria and Inflammatory Biomarkers in Diabetic Nephropathy: a Clinical Trial on Type 2 Diabetes Mellitus". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00419835. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*